"or many years, the sentiment on this forum has been clear: to truly unlock Neuren Pharmaceuticals’ (NEU) full potential, a NASDAQ listing should be a top priority."
Umm - lol, NO ! laughable statement, NASDAQ has barely been discussed when compared to the real deal which is PhIII trials for their new drug, Daybue sales and also a potential Buyout or takeover.
These topics and sentiments have been way, WAAAY more prevalent than a frivolous and useless NASDAQ listing discussion.
IMO this would be a unnecessary diversion from the main game - and will likely result in even more SP and MC manipulation.
"or many years, the sentiment on this forum has been clear: to...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$15.39 |
Change
0.550(3.71%) |
Mkt cap ! $1.915B | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.50 | $14.91 | $9.641M | 631.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $15.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.39 | 1224 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |